Showing results (1-10 of 222) with videos related to
Sort By:
Pageof 23
Expert Review of Anticancer Therapy|September 21, 2011
Choosing first-line therapy for chronic lymphocytic leukemiaSamantha Jaglowski, Jeffrey A JonesCurrent Problems in Cancer|January 11, 2022
CAR T-cell therapy for B-cell lymphomaNathan Denlinger, David Bond, Samantha JaglowskiClinical Lymphoma, Myeloma & Leukemia|April 20, 2024
SOHO State of the Art Updates and Next Questions Updates on Building Your CAR-T Cell ProgramTimothy J Voorhees, Evandro Bezerra, Nathan Denlinger, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 28, 2020
Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best PracticesMonica Ardura, David Hartley, Christopher Dandoy, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 10, 2019
Carfilzomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Pilot Phase II TrialJoseph Pidala, Samantha Jaglowski, Annie Im, et al.Seminars in Oncology|April 5, 2016
Bruton tyrosine kinase inhibition in chronic lymphocytic leukemiaKami Maddocks, Jeffrey A JonesCurrent Cardiology Reports|April 29, 2010
The pathogenesis of aortopathy in Marfan syndrome and related diseasesJeffrey A Jones, John S IkonomidisThe Journal of Biological Chemistry|February 22, 2002
Tight binding inhibition of protein phosphatase-1 by phosphatidic acid. Specificity of inhibition by the phospholipidJeffrey A Jones, Yusuf A HannunBlood|January 8, 2014
How will B-cell-receptor-targeted therapies change future CLL therapy?Jeffrey A Jones, John C ByrdAdvances in Experimental Medicine and Biology|November 22, 2021
Pathophysiology and Pathogenesis of Marfan SyndromeSanford M Zeigler, Brandon Sloan, Jeffrey A JonesPageof 23